Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Perspectives in multiple sclerosis research]

H Lassmann1

  • 1Klinischen Institut für Neurologie, Universität Wien. hans.jassmann@univie.ac.at

Wiener Medizinische Wochenschrift (1946)
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study.

Frontiers in neurology·2022
Same author

PDE10A antibodies in autoimmune encephalitis: A possible marker of cancer immunotherapy?

Neurology·2019
Same author

Pro-inflammatory activation of microglia in the brain of patients with sepsis.

Neuropathology and applied neurobiology·2018
Same author

CNS neuroimmunology seen by a neuropathologist.

Revue neurologique·2014
Same author

TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2014
Same author

Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2012
Same journal

Necrotizing fasciitis of the thigh-a devastating sign of intestinal perforation.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Regenerative therapies in rehabilitation with interfaces with occupational medicine, geriatrics, and oncology: the example of extracorporeal shock wave therapy.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Cerebral toxoplasmosis in patients with peripheral B-cell lymphoma : A case series and a literature review.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Post-pandemic rebound of rotavirus and adenovirus in pediatric gastroenteritis: a 6-year antigen-based surveillance study from Turkey.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Neuroaxis involvement in Chikungunya virus infection: a retrospective case series.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

A complicated case of a spinal Scedosporium apiospermum infection with a favorable outcome-case report.

Wiener medizinische Wochenschrift (1946)·2026
See all related articles

Multiple sclerosis (MS) involves complex immune responses. Research suggests diverse mechanisms cause MS inflammation and myelin damage, necessitating patient subgroup categorization for effective therapies.

Area of Science:

  • Immunology
  • Neuroscience
  • Pathology

Context:

  • Multiple sclerosis (MS) is recognized as an immune-mediated neurological disorder.
  • The precise immunological pathways driving MS-related inflammation and demyelination remain debated.
  • Existing research highlights variability in the inflammatory and demyelinating processes observed in MS patients.

Purpose:

  • To review current evidence on the heterogeneous immunological mechanisms underlying multiple sclerosis.
  • To explore how variations in antigen specificity and myelin destruction pathways contribute to MS.
  • To discuss strategies for improved patient stratification in future therapeutic trials.

Summary:

  • Evidence suggests that multiple sclerosis (MS) pathogenesis is not uniform across all patients.

Related Experiment Videos

  • Heterogeneous mechanisms, including diverse immune responses and myelin damage processes, contribute to inflammatory demyelinating plaques.
  • This immunological heterogeneity impacts the design and interpretation of clinical studies.

    • Impact:

    • Understanding MS pathogenetic heterogeneity is crucial for developing targeted therapies.
    • Accurate patient subgroup categorization can enhance the efficacy of clinical trials.
    • This research informs future strategies for personalized medicine in multiple sclerosis treatment.